Search - tctmd.com

Displaying 281 - 300 of 363

Sort: Relevancy | Date

Presentation THT 2023

Advanced Heart Failure in ACHD - How Do We Define It?

Presenter: Christopher Learn

March 20, 2023

Presentation THT 2023

CCM® - Don’t Wait !

Presenter: Andrew Sauer

March 20, 2023

Presentation THT 2023

The AccuCinch Procedure: A Case Presentation

Presenter: Kendra Grubb

March 20, 2023

Presentation THT 2023

CCM® - Body of Evidence – What We Know and What We’re Learning

Presenter: Javed Butler

March 20, 2023

Presentation THT 2023

Treating the Failing Heart From Inside the LV Chamber: The AccuCinch Approach

Presenter: Ulrich Jorde

March 20, 2023

Presentation THT 2023

Conventional HF Management – Is There a Problem, and Whose Problem Is It?

Presenter: William Abraham

March 20, 2023

Presentation THT 2023

When and Why to Consider New Treatments for Our HF Patients

Presenter: Jacob Abraham

March 20, 2023

Presentation THT 2023

ATTR-CM is a serious and underrecognized cause of heart failure. This program will help raise awareness of the signs and symptoms of ATTR-CM, the role of cardiac health professionals in diagnosis, and a treatment option for patients with ATTR-CM

Presenter: Charles Dow

March 20, 2023

Presentation THT 2023

Artificial Intelligence Will Revolutionize Risk Stratification and Guide Therapy for Cardiogenic Shock

Presenter: Song Li

March 20, 2023

Presentation THT 2023

Applications of Gene Therapy in Cardiomyopathies (TBD)

Presenter: Eric Adler

March 20, 2023

Presentation THT 2023

Biomarkers and Risk Stratification for Cardiogenic Shock

Presenter: Ajar Kochar

March 20, 2023

Presentation THT 2023

How SCAI Classification Has Revolutionized Approach to Cardiogenic Shock

Presenter: David Baran

March 20, 2023

Presentation THT 2023

Emerging Medical Pathways for Heart Failure Therapies

Presenter: Steven Marx

March 20, 2023

Presentation THT 2023

Treating the Right Ventricle in Cardiogenic Shock: the Next Frontier in Improving Outcomes

Presenter: Michele Esposito

March 20, 2023

Presentation THT 2023

The Role of Monitoring Devices in Optimizing Medical Therapies

Presenter: Anu Lala-Trindade

March 20, 2023

Presentation THT 2023

Intra-Aortic Balloon Counterpulsation: "I'll Be Back"

Presenter: Sandeep Nathan

March 20, 2023

Presentation THT 2023

Trans-Valvular LV Support: a Glimpse Into the Future

Presenter: Colin Hirst

March 20, 2023

Presentation THT 2023

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

Presenter: John Teerlink

March 20, 2023

Presentation THT 2023

What Do We Really Know About ECMO in Cardiogenic Shock?

Presenter: Navin Kapur

March 20, 2023

Presentation THT 2023

When To Transition From Medical to Device-Based Therapy

Presenter: Shelley Hall

March 20, 2023

Advertisement

Advanced Heart Failure in ACHD - How Do We Define It?

CCM® - Don’t Wait !

The AccuCinch Procedure: A Case Presentation

CCM® - Body of Evidence – What We Know and What We’re Learning

Treating the Failing Heart From Inside the LV Chamber: The AccuCinch Approach

Conventional HF Management – Is There a Problem, and Whose Problem Is It?

When and Why to Consider New Treatments for Our HF Patients

ATTR-CM is a serious and underrecognized cause of heart failure. This program will help raise awareness of the signs and symptoms of ATTR-CM, the role of cardiac health professionals in diagnosis, and a treatment option for patients with ATTR-CM

Artificial Intelligence Will Revolutionize Risk Stratification and Guide Therapy for Cardiogenic Shock

Applications of Gene Therapy in Cardiomyopathies (TBD)

Biomarkers and Risk Stratification for Cardiogenic Shock

How SCAI Classification Has Revolutionized Approach to Cardiogenic Shock

Emerging Medical Pathways for Heart Failure Therapies

Treating the Right Ventricle in Cardiogenic Shock: the Next Frontier in Improving Outcomes

The Role of Monitoring Devices in Optimizing Medical Therapies

Intra-Aortic Balloon Counterpulsation: "I'll Be Back"

Trans-Valvular LV Support: a Glimpse Into the Future

Beyond the Four Foundational Therapies: Vericiguat and Omecamtiv Mecarbil

What Do We Really Know About ECMO in Cardiogenic Shock?

When To Transition From Medical to Device-Based Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content